1. Home
  2. XRAY vs BCRX Comparison

XRAY vs BCRX Comparison

Compare XRAY & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DENTSPLY SIRONA Inc.

XRAY

DENTSPLY SIRONA Inc.

HOLD

Current Price

$11.70

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$8.89

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XRAY
BCRX
Founded
1899
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.4B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
XRAY
BCRX
Price
$11.70
$8.89
Analyst Decision
Hold
Strong Buy
Analyst Count
14
11
Target Price
$14.58
$20.82
AVG Volume (30 Days)
3.0M
3.9M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
5.43%
N/A
EPS Growth
33.04
381.40
EPS
N/A
1.21
Revenue
N/A
$25,186,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.06
$12.55
P/E Ratio
N/A
$7.38
Revenue Growth
N/A
N/A
52 Week Low
$9.85
$6.00
52 Week High
$17.18
$11.31

Technical Indicators

Market Signals
Indicator
XRAY
BCRX
Relative Strength Index (RSI) 44.80 46.11
Support Level $10.96 $8.73
Resistance Level $12.28 $9.14
Average True Range (ATR) 0.44 0.36
MACD -0.01 -0.12
Stochastic Oscillator 13.91 23.59

Price Performance

Historical Comparison
XRAY
BCRX

About XRAY DENTSPLY SIRONA Inc.

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Share on Social Networks: